In order to determine whether the iodine intake influences the diagnostic power of ultrasound-guided fineneedle aspiration cytology (US-FNAC), patients with nontoxic nodular goiter from an area with sufficient iodine intake (IS) (n 5 938, median iodine excretion [MIE] 5 103 mg/L) and from an iodine-deficient (ID) area (n 5 3601, MIE = 75 mg/L) were investigated. Elevated rates of multinodularity (59.6% vs. 49.6%, p , 0.001), nonpalpable nodules (47.6% vs. 37.3%, p , 0.001) and nondiagnostic US-FNACs (8.8% vs. 5.1%, p 5 0.008), and a lower malignancy rate (1.2% vs. 2.3%, p 5 0.006) were found in the ID area. Follicular tumors were encountered among positive findings. Cytohistologic comparison (ID, n 5 416; IS, n 5 97) revealed that the sensitivity, specificity, and diagnostic accuracy of US-FNAC were similar in the two areas (95.5% vs. 92.3%, 78.3% vs. 71.1%, 82.4% vs. 80.6%, IS vs. ID area, respectively), while a lower malignancy rate and a higher ratio of benign to malignant tumors were observed in the ID than in the IS area (10.1% vs. 22.6%, p , 0.001, and 4.38 vs. 1.50, p , 0.001, respectively).